Key PointsEli Lilly's tirzepatide is showing potential across autoimmune diseases.
Great News for Eli Lilly Stock Investors
Key PointsEli Lilly's tirzepatide is showing potential across autoimmune diseases....
By Dhallo News · September 3, 2026 at 11:50 PM IST
Have feedback on this article?Report error or suggestion
